Mar 14, 2024
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.29 to $0.01.
The split itself did not change the total investment value.
Outlook Therapeutics, Inc. (OTLK) trades on the NASDAQ Capital Market in the Biotechnology industry.
Outlook Therapeutics, Inc. company overviewThe latest split shown was on March 14, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 2 reverse splits between March 18, 2019 and March 14, 2024.